1. Home
  2. NRXS vs GCV Comparison

NRXS vs GCV Comparison

Compare NRXS & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$7.31

Market Cap

78.9M

Sector

N/A

ML Signal

HOLD

Logo Gabelli Convertible and Income Securities Fund Inc. (The)

GCV

Gabelli Convertible and Income Securities Fund Inc. (The)

HOLD

Current Price

$4.45

Market Cap

92.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRXS
GCV
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
78.9M
92.5M
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
NRXS
GCV
Price
$7.31
$4.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
120.5K
25.6K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
22.13
N/A
EPS
N/A
N/A
Revenue
$3,569,282.00
N/A
Revenue This Year
$172.91
N/A
Revenue Next Year
$115.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
32.89
N/A
52 Week Low
$2.21
$3.98
52 Week High
$9.33
$4.80

Technical Indicators

Market Signals
Indicator
NRXS
GCV
Relative Strength Index (RSI) 64.73 42.27
Support Level $7.17 $4.42
Resistance Level $7.62 $4.54
Average True Range (ATR) 0.39 0.07
MACD 0.20 -0.01
Stochastic Oscillator 71.64 43.75

Price Performance

Historical Comparison
NRXS
GCV

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive, and others. All the operation of the group is operated through the regions of the United States.

Share on Social Networks: